Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak in Relapsed/Refractory B-Cell NHL
NCT00138164Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Dec 2004
- Primary completion
- Feb 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in B-cell non-Hodgkin lymphoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Dec 2004; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00138164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138164.